Mindfulness Meditation in Hemodialysis Patients (NCT07620990) | Clinical Trial Compass
RecruitingNot Applicable
Mindfulness Meditation in Hemodialysis Patients
Cyprus50 participantsStarted 2026-04-15
Plain-language summary
This randomised controlled study aims to evaluate the effects of mindfulness meditation on sleep quality, perceived stress and symptoms levels ion hemodialysis patients. Participants in the intervention group will receive a 4 week mindfulness meditation program in addition to routine care. Outcomes will be assessed before and after the intervention using validated measurement tools.
Who can participate
Age range
18 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients aged between 18 and 75 years
* Patients receiving hemodialysis treatment for at least 3 months
* Patients with cognitive functions suitable for the intervention (dementia score ≥21)
* Patient without hearing, vision or communication problems
* Patients without a psychiatric diagnosis
* Patients able to use a smartphone or tablet
* Patients not participating in another study
* Patients not using sleep medication or antipsychotic drugs
Exclusion Criteria:
* Patients younger than 18 years or older than 75 years
* Patients receiving hemodialysis treatment for less than 3 months
* Patients with cognitive impairment unsuitable for the intervention (dementia score ≤21)
* Patient with hearing, vision or communication disabilities
* Patients diagnosed with psychiatric disorders
* Patients unable to use a smartphone or tablet
* Patients participating in another study
* Patients using sleep medication or antipsychotic drugs
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Pittsburgh Sleep Quality İndex (PSQİ) Score
Timeframe: Baseline and 4 weeks after intervention
2
Perceived Stress Scale (PSS) Score
Timeframe: Baseline and 4 week after intervention.
3
Dialysis Symptom İndex (DSİ)
Timeframe: Baseline and 4 weeks after intervention.